ARTICLE | Clinical News
Fazaclo clozapine regulatory update
March 15, 2004 8:00 AM UTC
CIMA said the FDA approved Alamo's Fazaclo to treat severe schizophrenia in patients who fail to respond to standard drug treatment. CIMA will manufacture the orally disintegrating tablet formulation ...